Anti-IL6 treatment of serious COVID-19 disease: A monocentric retrospective experience

COVID-19 is causing a high influx of patients suffering from serious respiratory complications leading the necessity to find effective therapies. These patients seem to present with cytokine perturbation and high levels of IL6. Tocilizumab and sarilumab could be effective in this condition. We retro...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Medicine (Baltimore)
Main Authors: Castelnovo, Laura, Tamburello, Antonio, Lurati, Alfredo, Zaccara, Eleonora, Marrazza, Maria Grazia, Olivetti, Micol, Mumoli, Nicola, Mastroiacovo, Daniela, Colombo, Daniele, Ricchiuti, Elisabetta, Vigano’, Paolo, Paola, Faggioli, Mazzone, Antonino
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2021
Assuntos:
4900
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7793456/
https://ncbi.nlm.nih.gov/pubmed/33429732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000023582
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados